pentobarbital will lower the extent or effect of roflumilast by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration not recommended; sturdy cytochrome P450 enzyme inducers lessen systemic exposure to roflumilast and may reduce the therapeutic usefulnessInstead of learning the tectonic shifts on the overall eco